Status:

ACTIVE_NOT_RECRUITING

Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer

Lead Sponsor:

City of Hope Medical Center

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Breast Ductal Carcinoma In Situ

Invasive Breast Carcinoma

Eligibility:

FEMALE

18+ years

Phase:

PHASE1

Brief Summary

This clinical trial compares two supplemental topical agents (Aquaphor and Miaderm) for the treatment of acute radiation dermatitis in patients with breast cancer undergoing radiation therapy. Radiati...

Detailed Description

PRIMARY OBJECTIVE: I. Determine the efficacy of Miaderm compared to Aquaphor in the treatment and/or prevention of radiation dermatitis caused by EBRT in breast cancer patients undergoing EBRT to the...

Eligibility Criteria

Inclusion

  • Documented informed consent of the participant and/or legally authorized representative.
  • Age \> 18 years.
  • Undergoing external beam radiation therapy (EBRT) to the breast or chest wall following surgical resection (lumpectomy or mastectomy) for ductal carcinoma in situ (DCIS) or invasive breast cancer using either conventional fractionation or hypofractionation.

Exclusion

  • Partial breast irradiation.
  • Prior radiation overlapping with the intended radiotherapy field.
  • History of systemic radiation sensitivity diseases (xeroderma pigmentosum, ataxia telangiectasia).
  • Extreme hypofractionation (less than 15 fractions of radiation).
  • Palliative treatment.
  • Patient intention to use topical product other than Aquaphor or Miaderm.
  • Inflammatory breast cancer, skin involvement, planned use of bolus.

Key Trial Info

Start Date :

June 21 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 21 2025

Estimated Enrollment :

208 Patients enrolled

Trial Details

Trial ID

NCT05340673

Start Date

June 21 2022

End Date

December 21 2025

Last Update

August 5 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

City of Hope Medical Center

Duarte, California, United States, 91010